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1. INTRODUCTION 
In The great advances of modern scientific medicine, traditional medicine is 
still the primary form of treating diseases of majority of people in developing 
countries including India. even among those to whom western medicine is available, 
the number of people using one or another of complementary of alternative medicine 
is rapidly increasing worldwide. Increasing knowledge of metabolic process and the 
effect of plants on human physiology has enlarged the range of application of 
medicinal plants . 
Medicinal plants are a large group of  plants  used in  medicine or veterinary 
practices for therapeutic or prophylactic purposes. They have been identified and used 
throughout human history. Plants have the ability to synthesize a wide variety of 
chemical compounds that are used to perform important biological functions, and to 
defend against  predators such as insects, fungi and herbivorous mammals. At least 
12,000 such compounds have been isolated so far; a number estimated to be less than 
10% of the total. 
The term of medicinal plants include a various types of plants used in 
herbalism and some of these plants have a medicinal activities. These medicinal 
plants consider as a rich resources of ingredients which can be used in drug 
development and synthesis. Besides that these plants play a critical role in the 
development of human cultures around the whole world. Moreover, some plants 
consider as important source of nutrition and as a result of that these plants 
recommended for their therapeutic values. 
 Mainly in three ways medicinal plants  has been found their use in medicine; 
 They used directly or their natural chemical constituents are used 
 They used as an agent in the synthesis of drugs 
 Their organic molecules are used as a model for synthesis of drugs 
Therapeutic properties of medicinal are identified mainly by the presence of 
alkaloids, glycosidess, flavanoids, vitamins, tannins, or coumarin  derivatives in their 
organs. 
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All plants produce chemical compounds as part of their 
normal metabolic activities. These phytochemical  are divided into (1) primary 
metabolites such as sugars and fats, which are found in all plants; and (2) secondary 
metabolites compounds which are found in a range of plants, serving a more specific 
function. Plants synthesize a bewildering variety of phytochemicals but most are 
derivatives of a few biochemical motifs. 
Alkaloids are a class of chemical compounds containing a nitrogen ring. 
Alkaloids are produced by a large variety of organisms, including bacteria, fungi, 
plants, and animals, and are part of the group of natural products (also called 
secondary metabolites). Many alkaloids can be purified from crude extracts by acid-
base extraction. They often have pharmacological effects and are used as medications, 
as recreational drugs, or in entheogenic rituals. Examples are the local anesthetic and 
stimulant cocaine; the psychedelic psilocin; the stimulant caffeine; nicotine; the 
analgesic morphine; the antibacterial berberine; the anticancer compound vincristine; 
the antihypertension agent reserpine. 
 Polyphenols (also known as phenolics) are compounds contain phenol rings. 
Glycosides is a molecule in which a sugar is bound to a non-carbohydrate moiety, 
usually a small organic molecule. Glycosides play numerous important roles in living 
organisms. 
 Terpenes are a large and diverse class of organic compounds, produced by a 
variety of plants, particularly conifers, which are often strong smelling and thus may 
have had a protective function. They are the major components of resin, and 
of turpentine produced from resin. 
1.1 Characteristics of Medicinal Plants  
 Medicinal plants have many characteristics when used as a treatment, as 
follow: 
 Synergic medicine- The ingredients of plants all interact simultaneously, so 
their uses can complement or damage 
 others or neutralize their possible negative effects. 
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 Support of official medicine- In the treatment of complex cases like cancer 
diseases the components of the plants proved to be very effective. 
 Preventive medicine- It has been proven that the component of the plants also 
characterize by their ability to prevent the appearance of some diseases. This 
will help to reduce the use of the chemical remedies which will be used when 
the disease is already present i.e., reduce the side effect of synthetic treatment. 
There are approximately half million plants with flowers, most  of which have 
been investigated and which principles could be decive in the treatment of present or 
future diseases. 
India is surrounded by water on its three sides, the west coast consist of the 
Western Ghats extending from Tapti in Gujarat to Kanniyakumari in Tamil Nadu 
including Maharashtra, Goa, Karnataka and Kerala. The Western Ghats are stretch of 
hill ranges which are known to be rich in flora and fauna, comprising about 17000 
species of flowering plants are estimated in India of which, 4500 species a families of 
flowering plants comprising 19 genera and 400 species widely distributed, among 
which the genus comprises 80 species (Mabberley DJ, 1987). There are five species 
of excluding the cultivated M. fragrans in the Western Ghats region of Karnataka. 
They are attenuata, M. malabarica  var. magnifica, M. malabarica in Myristica swamp 
forest, which is the habitat of this species. Due to anthropological activity and 
conversion of this habitat to cash crop plantations and teak forests, the fresh water 
swamp now dwindled to small fractions in Karnataka (Rama Bhat P. and Kaveriappa 
KM, 2009). M. malabarica  Houtt. var. magnifica (Beddome) Sinclair is a lofty tree 
up to 30 m tall, trunk when young furnished with large aerial roots from the trunk. 
Leaves oblong to elliptic, rounded at base, acute to acuminate at ape 1a). Flowers in 
clusters, small, deciduous, ovoid, up to 2cm long densely rusty tomentose. Male 
flowering is 10 flowered cymes or umbels of 2-3cm long stamens 10. Female flowers 
are 4 (Rama Bhat P. and Kaveriappa KM, 1996. Fruits oblong, up to 10 cm long 
densely tomentose. Seeds subcylindric or ellipsoid, up to 5cm long, aril deeply much 
laciniate, orange is endemic, rare and threatened. It is commonly known as Choora 
pannu, as Dodda yele Ramapatre in Kannada, Kotthapanu or Kothapayin or 
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Churapayin in Malayalam. Ghats: Kerala- Kollam, Kozhikode, Thiruvananthapuram; 
Karn (Rama Bhat P. and Kaveriappa KM, 2009). India has an ancient heritage of 
traditional medicine. The on the folklore practices and traditional aspects of 
therapeutically important natural products. Indian traditional medicines are based on 
various system including Ayurveda, Siddha, Unani and Homeopathy. Plants are one 
of the most important sources of medicine. Today the large numbers of drugs i plants 
are rich in secondary metabolites and essential oils of therapeutic importance. The 
important advantages claimed PALGO JOURNAL OF MEDICINE AND MEDICAL 
SCIENCE .com Phytochemical screening, antimicrobial and antioxidant Myristica 
malabarica  Houtt. var. magnifica Sinclair Medha Tantry and Rama Bhat P. PG Dept. 
of Biotechnology, Alva’s College, Moodbidri – 574 227, Karnataka, India Accepted 
10 October, 2016 The methanolic and aqueous seed extracts of Myristica malabarica  
var. magifica were obtained by soxhlet method and used for biochemical studies 
including antimicrobial and antioxidant activities using standard protocols. showed 
the presence of phytochemical constituents like carbohydrates, proteins, alkaloids 
resins whereas the aqueous extract showed the absence of phenolics, tannin and resin. 
Antimicrobial activities were bacterial species viz., Staphylococcus aureus, 
Escherichia coli, Salmonella typhi, Klebsiella by agar well diffusion method. Out of 
two extracts, methanol extract were found to be more active against all the 
microorganisms than the aqueous extract. Antioxidant activity was determined by 
DPPH method which showed antioxidant potential of methanolic extract compared 
with the standard ascorbic acid. , antimicrobial activity, antioxidant activity, Myristica 
malabarica  India is surrounded by water on its three sides, the west coast consist of 
the Western Ghats extending from Tapti in in Tamil Nadu including Maharashtra, 
Goa, Karnataka and Kerala. The Western Ghats are stretch of hill ranges which are 
known to be rich in flora and fauna, comprising about 17000 species of flowering 
plants are estimated in India of which, 4500 species are found in the Western Ghats. 
Myristicaceae is one of the important families of flowering plants comprising 19 
genera and 400 species widely distributed, among which the genus comprises 80 
species. There are five species of Myristicaceae belonging to three genera in the 
Western Ghats region of Karnataka. They are magnifica, M. malabarica and M. 
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dactyloides. M. malabarica  var. magnifica swamp forest, which is the habitat of this 
species. Due to anthropological activity and conversion of this habitat to cash crop 
plantations and teak forests, the fresh water swamp now dwindled to small fractions in 
Karnataka ma Bhat P. and Kaveriappa KM, 2009). (Beddome) Sinclair is a lofty tree 
up to 30 m tall, trunk when young furnished with large aerial roots from the trunk. 
Leaves oblong to elliptic, rounded at base, acute to acuminate at ape 1a). Flowers in 
clusters, small, deciduous, ovoid, up to 2cm long densely rusty tomentose. Male 
flowering is 10 3cm long stamens 10. Female flowers are 4-6 flowered cymes or 
umbels of 1 ama Bhat P. and Kaveriappa KM, 1996. Fruits oblong, up to 10 cm long 
densely tomentose. Seeds subcylindric or ellipsoid, up to 5cm long, aril deeply much 
laciniate, orange-red (Plate 1b). Flowering and fruiting from March hreatened. It is 
commonly known as Choora pannu, as Dodda yele Ramapatre in Kannada, 
Kotthapanu or Kothapayin or Churapayin in Malayalam. It is distributed in as 
remnant patches in Southern Western Kollam, Kozhikode, Thiruvananthapuram; 
Karnataka-Uttara Kannada, Shimoga; Tamil Nadu. India has an ancient heritage of 
traditional medicine. The Materia Medica of India provides a great deal of 
information l aspects of therapeutically important natural products. Indian traditional 
medicines are based on various system including Ayurveda, Siddha, Unani and 
Homeopathy. Plants are one of the most important sources of medicine. Today the 
large numbers of drugs in use are derived from plants  plants are rich in secondary 
metabolites and essential oils of therapeutic importance. The important advantages 
claimed Phytochemical screening, antimicrobial and antioxidant magnifica , 
Karnataka, India were obtained by soxhlet method and used for biochemical studies 
including antimicrobial and antioxidant activities using standard protocols. 
Methanolic extract proteins, alkaloids, tannins, phenolics and . Antimicrobial 
activities were Escherichia coli, Salmonella typhi, Klebsiella by agar well diffusion 
method. Out of two extracts, methanol extract were found to be than the aqueous 
extract. Antioxidant activity was determined by DPPH method which showed 
antioxidant potential of methanolic extract compared with the standard ascorbic acid. 
Myristica malabarica  var. magnifica. India is surrounded by water on its three sides, 
the west coast consist of the Western Ghats extending from Tapti in in Tamil Nadu 
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including Maharashtra, Goa, Karnataka and Kerala. The Western Ghats are stretch of 
hill ranges which are known to be rich in flora and fauna, comprising about 17000 
species of flowering plants re found in the Western Ghats. Myristicaceae is one of the 
important families of flowering plants comprising 19 genera and 400 species widely 
distributed, among which the genus Myristica Myristicaceae belonging to three 
genera in the Western Ghats region of Karnataka. They are G. farquhariana, Knema 
magnifica is dominant species found swamp forest, which is the habitat of this 
species. Due to anthropological activity and conversion of this habitat to cash crop 
plantations and teak forests, the fresh water swamp now dwindled to small fractions in 
Karnataka (Beddome) Sinclair is a lofty tree up to 30 m tall, trunk when young 
furnished with large aerial roots from the trunk. Leaves oblong to elliptic, rounded at 
base, acute to acuminate at apex, silvery beneath. Flowers in clusters, small, 
deciduous, ovoid, up to 2cm long densely rusty tomentose. Male flowering is 10-20 6 
flowered cymes or umbels of 1-2cm long ama Bhat P. and. Fruits oblong, up to 10 cm 
long densely tomentose. Seeds subcylindric or red (Plate 1b). Flowering and fruiting 
from March-October. It hreatened. It is commonly known as Choora pannu, as Dodda 
yele Ramapatre in Kannada, It is distributed in as remnant patches in Southern 
Western Uttara Kannada, Shimoga; Tamil Nadu- Tirunelveli of India provides a great 
deal of information l aspects of therapeutically important natural products. Indian 
traditional medicines are based on various system including Ayurveda, Siddha, Unani 
and Homeopathy. Plants are one of the most important n use are derived from plants. 
The medicinal plants are rich in secondary metabolites and essential oils of 
therapeutic importance.  
Therapeutic uses of medicinal plants in various ailments are their safety 
besides being economical, effective and their easy availability. The chemical 
compounds that occur naturally in plants and responsible for colour and organoleptic 
properties, such as deep purple of blue berries and smell of garlic are called 
photochemicals. These phytochemicals may have biological significance but are not 
established as essential nutrients. Scientists estimates that there may be as many as 
10,000 different phytochemicals having the potential to affect diseases such as cancer, 
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stroke or metabolic syndrome. These phytochemicals are abundant in fruits, 
vegetables and herbs. The use of plant extracts and phytochemicals, both with known 
antimicrobial properties, are of great significance to therapeutic treatments. Extracts 
of plants were used for the treatment of various diseases and this forms the basis for 
all Indian system of medicines. However this area is not much developed when 
compared to modern system of medicines, mainly because of the lack of scientific 
documentation in this field. Recent investigations revealed that plant origin 
antioxidants have great therapeutic importance in free radical mediated diseases like 
diabetes, cancer, neurogenerative diseases, cardiovascular diseases, aging, 
gastrointestinal diseases. Many synthetic antioxidant compounds have shown toxic 
and/or mutagenic effect; while relatively plant based medicine confer fewer side 
effects than the synthetic drugs in some instances. Myristica malabarica  var. 
magnifica belongs to the family Myristicaceae (nutmeg family). The other species of 
this family contains antimicrobial and antioxidant activity. There is one report on the 
use of aril covering the seed of this plant used as dyeing in Dakshina Kannada; the 
wood has no other uses. The above properties may be present in M. malabarica  var. 
magnifica seeds and arils. So a detailed study is required for analysis. But exploitation 
of plant should be narrowed as the species is listed in the RED List of Plants which 
needs special care of conservation strategy. Conservation of habitat as well as fresh 
water ecosystem – the Myristica swamp needs first rank of attention in the 
biodiversity conservation acts. The seeds are of recalcitrant type, looses viability 
rapidly. Nutmeg (M. fragrans) contains many plant-derived chemical compounds that 
are known to have been anti-oxidant, disease preventing, and health promoting 
properties. The active principles in nutmeg have many therapeutic applications in 
many traditional medicines as anti-fungal, anti-depressant, aphrodisiac, digestive, and 
carminative functions. Alcoholic extract of nutmeg have antibacterial activity against 
Micrococcus pyrogenes var. aureus. Aqueous decoctions are toxic to cockroaches. 
Myristicin is used as an additive to pyrethrum to enhance its toxicity against 
houseflies. The leaf essential oils have weedicidal properties. It is also used for 
making soaps, dentifrices, chewing gums and tobacco. Nutmeg pericarp is used in 
pickles and jellies. Nutmeg oil contains eugenol, which has been used in dentistry for 
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toothache relief. The oil is also used as a local massage to reduce muscular pain and 
rheumatic pain of joints. Freshly prepared decoction with honey has been used to 
relief of nausea, gastritis, and indigestion ailments. On the other hand M. malabarica 
(wild nutmeg) seed used in external application for indolent ulcers, crude fat from 
seeds analgesic and used in rheumatism and gangrene. The yellowish maize is used as 
an adulterant for true mace. The seed and aril extracts possess antifungal and 
antibacterial activity. Based on the above observations a research study has been 
undertaken with the following objectives:   To analyse the phytochemical 
constituents in the aqueous and methanolic extract of the seed of Myristica malabarica  
var. magnifica.   To evaluate antimicrobial activity of methanolic and aqueous 
extract on selected bacterial and fungal strains.   To study the antioxidant activity of 
aqueous and methanolic extracts of the seed of M. malabarica  var. magnifica. 
1.2 CANCER : 
Cancer is a rapid creation of abnormal cells that grow  beyond their usual 
boundaries, and which can then invade adjoining parts of the body and spread to other 
organs or cancer is a generic term for a large group of disease that affect any part of 
the body. The abnormal cells are termed cancer cells, malignant cells, or tumor cells. 
It is a common condition and a serious health problem. Cancer is a leading cause of 
death worldwide. One in three people will develop some forms of cancer during their 
lifetime. Lung, stomach, liver, colon, and breast cancer cause the most cancer deaths 
each year. Deaths from cancer worldwide are projected to continue rising, with an 
estimated 12 million deaths in 2030. Cancer is not confined to humans; animals and 
other living organisms can get cancer. . Cancer, in medicine, common term for 
neoplasms, or tumors, that is malignant. Like benign tumors, malignant tumors do not 
respond to normal body mechanism, that controls normal cell growth. Malignant 
tumors consist of undifferentiated, or unspecified, cells that show an atypical cell 
structure and do not function like the normal cells from the organ from which it 
derives. Cancer cells lack contact inhibition. Loss of contact inhibition accounts for 
two other characteristics of cancer cells; invasiveness of surrounding tissues, and 
metastasis, or spreading via lymphatic system or blood to other tissues and organs. 
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Normal cells have a limited lifespan controlled by the telomere gene, which signals 
the end of cell life. Cancer cell contains telomerase, an enzyme that alters the 
telomere gene and allow the cell continue to divide. Cancers tissue, growing without 
limits, competes with normal tissue for nutrients, eventually killing normal tissue by 
nutritional deprivation. Cancerous tissue also cause secondary effects, in which the 
expanding malignant growth puts pressure on surrounding tissue or organs or the 
cancer cells that metastasis and invade other organs.21 
1.3 CLASSIFICATION [7] 
There are over 200 types of cancers; most can fit into the following categories. 
Cancers are classified by the type of cell that the tumor cells resemble and are 
therefore presumed to be the origin of the tumor. These types include: 
 Carcinoma: Cancers derived from epithelial cells. 
 Sarcoma: Cancers arising from connective tissue (i.e. bone, cartilage, fat, 
nerve), each of which develop from cells originating in mesenchymal cells 
outside the bone marrow. 
 Lymphoma and leukemia: These two classes of cancer arise from 
hematopoietic (blood-forming) cells that leave the marrow and tend to mature 
in the lymph nodes and blood, respectively. 
 Germ cell tumor: Cancers derived from pluripotent cells, most often 
presenting in the testicle or the ovary (seminoma and dysgerminoma, 
respectively). 
 Blastoma: Cancers derived from immature "precursor" cells or embryonic 
tissue 
1.4 SIGNS AND SYMPTOMS OF CANCER [8,9]. 
Symptoms and signs of cancer depend on the type of cancer, where it is 
located and capacity to spread. However, below specified signs and symptoms were 
the indication of cancer. 
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 Fever (no clear infectious source, recurrent or constant) 
 Fatigue (not relived by rest) 
 Weight loss (without trying to lose weight) 
 Pain (usually persistent) 
 Skin changes (coloration, sores that do not heal, white spots in mouth or on 
tongue, wart changes) 
 Change in bowel or bladder functions (including trouble swallowing or 
constipation) 
 Unusual bleeding (mouth, vaginal, and bladder) or discharge 
 Persistent cough or change in voice 
 Lumps or tissue masses 
1.5 DIAGNOSIS OF CANCER [10,11] 
Most cancers are initially recognized either because of the appearance of signs 
or symptoms or through screening. People with suspected cancer are investigated with 
medical tests. These commonly include blood tests, X-rays, CT scans and endoscopy. 
Imaging studies are commonly used to help physicians detect abnormalities in the 
body that may be cancer. The biopsy can provide more than the definitive diagnosis 
of cancer; it can identify the cancer type (for example, a primary or metastatic type of 
brain cancer) and the "stage" of the cancerous cells. 
Cancer treatment depends on the type of cancer, the stage of the cancer (how 
much it has spread), age, health status, and additional personal characteristics. There 
is no single treatment for cancer, and patients often receive a combination of therapies 
and palliative care [12,13]. Treatments usually fall into one of the following categories: 
 Surgery 
 Radiation 
 Chemotherapy 
 Immunotherapy 
 Hormone therapy 
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 Gene therapy 
 
1.6 SURGERY 
Surgery is the oldest known treatment for cancer. If a cancer has not 
metastasized, it is possible to completely cure a patient by surgically removing the 
cancer from the body. This is often seen in the removal of the prostate or a breast or 
testicle. 
1.7 RADIATION[14] 
Radiation therapy involves the use of ionizing radiation in an attempt to either 
cure or improve the symptoms of cancer. It is used in about half of all cases and the 
radiation can be from either internal sources in the form of brachytherapy or external 
sources. Radiation is typically used in addition to surgery and or chemotherapy but for 
certain types of cancer such as early head and neck cancer may be used alone. 
1.8 IMMUNOTHERAPY 
Immunotherapy aims to get the body's immune system to fight the tumor. 
Local immunotherapy injects a treatment into an affected area, Systemic 
immunotherapy treats the whole body by administering an agent such as the protein 
interferon alpha that can shrink tumors. 
 
1.9 HORMONE THERAPY 
Several cancers have been linked to some types of hormones, most notably 
breast and prostate cancer. Hormone therapy is designed to alter hormone production 
in the body so that cancer cells stop growing or are killed completely. 
1.10 GENE THERAPY[15] 
The goal of gene therapy is to replace damaged genes with ones that work to 
address a root cause of cancer: damage to DNA. . Other gene-based therapies focus on 
further damaging cancer cell DNA to the point where the cell commits suicide. Gene 
therapy is a very young field and has not yet resulted in any successful treatments. 
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1.11 PALLIATIVE CARE [16] 
Palliative care refers to treatment which attempts to make the patient feel 
better and may or may not be combined with an attempt to attack the cancer. 
Palliative care includes action to reduce the physical, emotional, spiritual, and psycho-
social distress experienced by people with cancer. Unlike treatment that is aimed at 
directly killing cancer cells, the primary goal of palliative care is to improve the 
patient's quality of life. 
1.12 PREVENTION OF CANCER [17] 
 Cancer prevention is defined as active measures to decrease the risk of cancer. 
The vast majority of cancer cases are due to environmental risk factors, and many, but 
not all, of these environmental factors are controllable lifestyle choices. Thus, cancer 
is considered a largely preventable disease. Greater than 30% of cancer deaths could 
be prevented by avoiding risk factors including: tobacco, overweight / obesity, an 
insufficient diet, physical inactivity, alcohol, sexually transmitted infections, and air 
pollution[18]. 
1.13 MEDICATION [19] 
 The concept that medications can be used to prevent cancer is attractive, and 
evidence supports their use in a few defined circumstances. In the general population 
NSAIDs reduce the risk of colorectal cancer however due to the cardiovascular and 
gastrointestinal side effects they cause overall harm when used for prevention. Aspirin 
has been found to reduce the risk of death from cancer by about 7%. COX-2 inhibitor 
may decrease the rate of polyp formation in people with familial adenomatous 
polyposis however are associated with the same adverse effects as NSAIDs. Daily use 
of tamoxifen or raloxifene has been demonstrated to reduce the risk of developing 
breast cancer in high-risk women. Vitamins have not been found to be effective at 
preventing cancer, although low blood levels of vitamin D are correlated with 
increased cancer risk. 
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1.14 VACCINATION 
 Certain vaccinations have been associated with the prevention of some 
cancers. For example, many women receive a vaccination for the human 
papillomavirus because of the virus's relationship with cervical cancer. Hepatitis B 
vaccines prevent the hepatitis B virus, which can cause liver cancer. 
 From modality of administration of herbal medication, anti-cancer herbal 
medicines are herein classified into 3 groups, including take by mouth, topical use and 
injectable preparations(not available at our HCC and HMC)[20]. Since1990, a research 
group of hi-tech herbal medicine directed by Dr. David Liu has conducted many 
studies on herbal treatments in chronic diseases and tumors. We have screened all 66 
sorts of anti-cancer medicinal herbs using our unique techniques, including identify 
and analysis of ester-soluble active ingredients , ethanol-soluble active ingredients 
and hydrate-soluble active ingredients in each potential anti-cancer medicinal herb or 
plant[21]. 
1.15 RECENT RESEARCH AND DEVELOPMENTS 
1.15.1 ANGIOGENESIS AND ANTIANGIOGENESIS [22] 
For the metastatic spread of cancer tissue, growth of the vascular network is 
important. The process whereby new blood vessels form is called angiogenesis. 
Angiogenesis is the physiological process through which new blood vessels form 
from preexisting vessels. The essential role of angiogenesis in tumor growth was first 
proposed by Judah Folkman1971. Angiogenesis has an essential role in the formation 
of a new vascular network to supply nutrients, oxygen and immune cells and also 
remove waste products. Angiogenesis has been correlated with disease progression 
and poor prognosis in many tumor types which can be activated at different stages of 
tumor development, depending on the tumor type and micro environmental 
conditions. Tumor growth and metastasis depends on angiogenesis triggered by 
chemical signals from tumor cells in a phase of rapid growth. Without angiogenesis 
cancer cells can’t grow beyond 2cumm or it can grow beyond 2cumm when 
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angiogenesis is possible. In the absence of vascular support tumors may become 
necrotic or even panoptic. Therefore angiogenesis is an important factor in the 
progression of cancer. Angiogenesis basically includes a four step process. First, the 
basement membrane in tissues is injured locally due to the interaction between tissue 
and carcinogens, which leads to immediate destruction and hypoxia. Second 
angiogenesis factors migrate?. Third, endothelial cells proliferate and stabilize and 
fourth is angiogenesis factor continue to influence the antigenic process. 
Angiogenesis is regulated by a balance between activators and inhibitors [23]. 
If angiogenesis is so critical for the tumor growth, then the agents that inhibit 
angiogenesis would have great therapeutic value. With the discovery of endostatin, 
the concept of anti-angiogenesis was launched. As early as the 1970s, Dr. Judah 
Folkman of the Harvard medical school suggested inhibiting new blood vessel 
formation as a way to fight cancer. Angiogenesis inhibitors can be discovered from a 
variety of sources. Some are naturally present in human body which fragments of 
structural proteins such as collagen or plasminogen. Others are natural products in 
green tea, soyabeans, fungi, mushrooms, tree barks, shark tissues, snake venom etc 
[24]
. 
  Recent research and developments is expressed biologically relevant data 
about the angiogenisis and anti angiogenisis treatments in the modern methods of 
medicinal practices-angiogenesis based Medicine which are restoring the body’s 
natural control of angiogenesis, it is a new, comprehensive approach to fighting 
against disease. By using new medical treatments that either inhibit or stimulate 
angiogenesis, doctors are prolonging the lives of cancer patients, preventing limb 
amputations, reversing vision loss and improving general health. In the synaryom of 
all cancerous tumors, for example, release angiogenic growth factor proteins that 
stimulate blood vessels to grow into the tumor, providing with oxygen and nutrients 
[25]
. Antiangiogenic therapies literally starve the tumor of its blood supply by 
interfering with this process. A new class of cancer treatments that block angiogenesis 
are now approved and available to treat cancers of the colon, kidney, lung, breast, 
liver, brain, and thyroid, as well as multiple myeloma, bone gastrointestinal stromal 
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tumors, soft tissue sarcoma, and SEGA tumors. Some older drugs have been 
rediscovered to block angiogenesis, as well. These are being used to treatment 
angiogenesis-dependent conditions, such as hemangiomas, colon polyps, and 
precancerous skin lesions [26]. 
 Therapeutic angiogenesis, in contrast, stimulates angiogenesis where it is 
required but lacking. This technique is used to replenish the blood supply to chronic 
wounds to speed healing, and it prevents unnecessary amputations [27].  New research 
suggests this approach can be also used to save limbs afflicted with poor circulation, 
and even oxygen-starved hearts. Therapeutic angiogenesis may even help to 
regenerate damaged or lost tissues in ways that were previously considered 
impossible, such as with nerves and brain tissue. In this data clearly mentioned about 
the importance of the angiogenesis and anti angiogenesis in modern medicinal 
practices [28]. Recently some literatures indicated different types of angiogenesis 
available such as sprouting and intususceptive29&30. 
DIFFERENT STAGES OF ANGIOGENESIS 
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ANTIANGIOGENESIS DRUGS  
 The steps involved in pathway are a possible target for cancer treatment. 
Different drugs may works at different step in this pathway. 
 Inhibiting endogenous angiogenic factors , such as BFGF and VEGF. 
 Inhibiting degenerative enzymes (matrix metalloproteinase) responsible for 
the degradation of the basement membrane of blood vessels. 
 Inhibiting endothelial cell proliferation. 
 Inhibiting endothelial cell migration. 
 Inhibiting activation and differentiation of endothelial drugs[31] 
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SIDE EFFECTS OF ANTI ANGIOGENIC DRUGS [32] 
 Angiogenic drugs have milder side effects than chemotherapy drugs. Anti 
angiogenic  drugs are fairly new, it’s not yet clear if the effects see so far will be seen 
with all the drugs. 
 Bleeding or holes in digestive tract 
 Raised blood pressure 
 Surgery risks 
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 Pregnancy risks 
 Newer approaches that combine anti angiogenic drugs with chemotherapy , 
other targeted drugs, or radiation may work better than using them alone. 
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2. LITERATURE REVIEW 
Banerjee Dmaity et.al.,2016 Investigated and reported The healing activity of the 
methanol extract of the  Myristica malabarica and omeprazole against indometacin-
induced stomach ulceration  in a mouse model. Treatment with RM (40 mg kg(-1) per 
day) and omeprazole (3 mg kg(-1) per day) for 3 days could effectively heal the 
stomach ulceration, as revealed from the ulcer indices and histopathological studies. 
Compared with the ulcerated group, treatment with RM and omeprazole for 3 days 
reduced the macroscopic damage score by approximately 72% and 76%, respectively 
(P<0.001), establishing the efficacy of RM. The extent of ulcer healing offered by 3 
days' treatment with RM or omeprazole was better than that observed with natural 
recovery over 5 and 7 days (P<0.05). The healing capacities of RM and omeprazole 
could be attributed to their antioxidant activity as well as the ability to enhance the 
mucin content of the gastric tissues. Both drugs reduced lipid peroxidation (by 42-
44%) and protein carbonyl content (by 34%), and augmented non-protein thiol levels 
beyond normal values. Furthermore, RM improved the mucin level beyond the 
normal value, while omeprazole restored it to near normalcy. 
Biswanath Maity et.al 2016 Studied and reported the  3rd day of its administration to 
mice, indomethacin (18 mg kg−1, p. o.) produced maximum stomach ulceration with a 
damage score of 3.46, which was reduced by a 3-day treatment with the methanol 
extract of Myristica malabarica (40 mg kg−1, p. o.) and omeprazole (3 mg kg−1, p. o.) 
to 0.95 and 0.82, respectively. Presently, they investigated the possible role of the test 
samples in modulating PG synthesis and angiogenesis for their healing action. The 
ulceration was found to be associated with suppression of PGE2, VEGF and vWF 
VIII, and an increase in EGF and endostatin levels. Treatment with the plant extract 
reversed all these parameters accounting for its healing activity. However, despite 
providing similar healing, omeprazole did not alter these parameters. 
 Babu et.al 2010 Studied the Biochemical aspects of  desiccation induced viability 
loss in myristica malabarica  by exposing freshly collected mature seeds. At the room 
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temperature 28± 2°C, and 60%RH.)Moisture content and germination rate were 
reduced uniformly and viability (72%) was retained up to 6 days when the moisture 
content was reduced to one half. Electrolyte leakage and lipid peroxidation showed 
linear increase while formozan intensity was reduced gradually until the loss of 
viability. Peroxidase andpolyphenoloxidase were more active up to 4th day of 
desiccation compared to the control whereas, drastic reduction in the activity of these 
enzymes was observed coinciding with loss of viability. Even though Myristica 
malabarica seeds containedonly 27% moisture content and were considered as 
moderately recalcitrant because these seeds were highly sensitive todesiccation and 
the loss of viability begans after one day and ends within 7-8days. The desiccation 
sensitivity appeared to be  due to manifold electrolyte leakage and lipid peroxidation 
and comparatively reduced enzymatic protection expressed asperoxidase and 
polyphenol oxidase against free radicals formed due to desiccation stress. 
Bauri et.al 2015  isolated the methanol extract of myristica malabarica and 
reported The title compound, malabaricone A [systematic name: 1-(2,6-
dihydroxyphenyl)-9-phenylnonan-1-one], C21H26O3, contains two benzene rings 
linked through a C9 alkyl chain. Both intra- and intermolecular O-H hydrogen-
bonding interactions stabilize the packing. The intermolecular hydrogen bonds result 
in the formation of an infinite zigzag chain. 
Choi Nam Hee-Kwon et.al 2008 Isolated the active constituent of malabaricones from 
the medicinal plant of myristica malabarica then  investigated about the nematicidal 
activity  against bursaphelenchus xylophilus and reported. Bursaphelenchus 
xylophilus,is the causative agent of pine wilt disease. the methanol extract of 
Myristica malabarica fruit rinds showed the most potent nematicidal activity with 
mortality of 100% at a concentration of 1000 μg ml-1 against B. xylophilus. Three 
nematicidal substances were isolated by bioassay-guided fractionation and then 
identified as malabaricones A, B and C by mass and NMR spectral data. Both 
malabaricones B and C showed higher activity than malabaricone A. There was a 
significant synergistic interaction between the three compounds on the pine wood 
nematode. When the combination of three compounds at a ratio of 1 : 1 : 1 was 
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applied, its EC50 value was 11.8 μg ml-1. These results indicate that the extract of M. 
malabarica containing the three resorcinols could be useful as a natural nematicide 
for the control of pine wilt disease. 
Consolacion Ragasa et.al 2016 Isolated the resorcinol from the plants of spiecies 
myristicaceae including myristica malabarica.The dichloromethane extract of the air-
dried leaves of Myristica philippensis afforded two resorcinols, 1 and 2, and  ȕ-
sitosterol. The structure of1 was elucidated by extensive 1D and 2D NMR 
spectroscopy and confirmed by mass  spectrometry and comparison of its 13C NMR 
data with those of malabaricone C . The structure of 2 was  deduced by comparison of 
its 1HNMR data with 1 and confirmed by comparison of its 13C NMR data with 
those of  malabaricone B . ȕ-Sitosterol was identified by comparison of its 1H NMR 
data with those reported in the  literature .  The resorcinols, malabaricone C  and 
malabaricone B isolated from M. philippensis have been previously  reported as 
constituents of M. fragrans , M. maingayi , M. gigantea , M. dactyloides and M. 
crassa  , while he was also reported as a constituent of M. malabarica and M. 
cinnamomea . Thus, these  resorcinols which were reported to exhibit various 
biological activities  are found in the genus Myristica of the family Myristicaceae. 
Indira iyer et.al 2008 Studied the  direct somatic embryogenesis was obtained from 
intact and fragmented zygotic embryos of Myristica malabarica, an endemic, 
threatened medicinal species of Western Ghats of Southern India while cultured in 
Murashige and Skoog medium containing activated charcoal. In the absence of 
activated charcoal there was no embryogenic response but only callus formation in 
zygotic embryos and their fragments. The addition of gibberellic acid resulted in the 
emergence of shoot from the somatic embryos. The various developmental stages of 
somatic embryos were examined using scanning electron microscope. Thin layer 
chromatography revealed the presence of compounds similar to lignans in the 
embryogenic mass. GC-MS analysis of the embryogenic mass revealed the presence 
of several compounds of potential clinical value including malabaricone A , α- 
spinasterol and Ȗ- sitosterol. The spent medium showed strong anti-bacterial activity 
against Pseudomonas aeruginosa. The results are significant since this is the first 
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report of tissue culture and induction of somatic embryogenesis in Myristica 
malabarica. The embryogenic culture system is potentially useful for efficient and 
consistent production of bioactive compounds and also has strong implications for 
conservation of its valuable germplasm. 
John Zachariah et.al 2006 Reported the Essential oil constituents of leaves of three 
Myristica species namely, Myristica beddomeii, M. fragransand M. malabarica were 
determined by gas chromatography and gas chromatography-massspectrometry. M. 
fragrans was dominated by monoterpenes (91%), M.  beddomeii contained mono-
(48%) and sesquiterpenes(35%) whereas M. malabarica was dominated by 
sesquiterpenes (73%).The leaf oil of M.  beddomeii was dominated by α-pinene 
(19.59%), t-caryophyllene (14.63%) andȕ-pinene (12.46%).  The leaf oil of M. 
fragrans contained sabinene (19.07%), α-pinene (18.04%), 4-terpineol (11.83%), 
limonene (8.32%) and  ȕ-pinene (7.92%) as major compounds, while t-caryophyllene 
(20.15%), α-humulene (10.17%), nerolidol (9.25%) and  δ-cadinene (6.72%) 
werepredominant in the oil of M. malabarica. Linalool, α-terpineol, t-caryophyllene, 
ȕ-elemene and Ȗ-elemene were present in all the three species. This is the first report 
on the essential oil compositionof M. beddomeii leaves. 
Kristi Dover et.al 2015 reviewed the pathophysiologic rationale and therapeutic 
applications of inhibiting angiogenesis in solid tumor growth.he investigated and 
reported the anti angiogenisis therapy is the useful and meaningful treatment option 
for the controlling malignant growth. Angiogenesis, the formation of new blood 
vessels, is necessary for the development of significant solid tumor growth. Inhibition 
of angiogenesis is a unique mechanism of antineoplastic therapy that does not use 
traditional cytotoxic actions. Four investigational antiangiogenic agents are currently 
being evaluated in phase I and II trials. Potentially beneficial applications of 
angiogenesis inhibitors include suppression of occult and premalignant lesions, 
symptomatic control of angiogenesis-dependent malignancies, and combination 
therapy with traditional antineoplastic agents. Finally he concluded that Inhibition of 
angiogenesis is a new pharmacologic strategy that may powerful in controlling 
malignant growth. A number of agents with antiangiogenic activity have been 
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developed, and further study of these drugs will define their role in antineoplastic 
therapy. 
Manjunatha et.al 2011 Investigated and reported the antioxidant activities of the 
ethanol extract of myristica malabarica. Benzene and chloroform fraction from seed 
aril of Myristica malabarica (Myristicaceae) were assessed in an effort to validate the 
hepatoprotective potency of this plant. The extract and the fractions showed 
scavenging of 1, 1-diphenyl-2picrylhydrazyl (DPPH) radical and inhibition of ABTS 
radical in vitro. Antioxidant activities of the extracts were also demonstrable in vivo 
by the inhibition of the carbon tetrachloride (CCl ) - induced formation of lipid 
peroxides in the liver of rats by 4 pretreatment with the extracts. CCl - induced 
hepatotoxicity in rats, as judged by the raised serum enzymes, 4 aspartate 
transaminase, alanine transaminase and alkaline phosphatases was prevented by 
pretreatment with the extracts/fractions, demonstrating the hepatoprotective action. 
Among the tested extracts benzene fraction recorded highest efficiency in protecting 
liver damage induced by toxic effect of CCl followed by crude 4 ethanolic extract and 
chloroform fraction. These findings were confirmed by histopathological study of the 
liver sections of the treated groups. 
Nam Hee Choi et.al 2008  Investigated plant extracts with in vivo antifungal activity 
for plant diseases, he found that the methanol extract of Myristica malabarica fruit 
rinds effectively suppressed the development of several plant diseases. The methanol 
extract exhibited potent 1-day protective activity against rice blast, tomato late blight, 
wheat leaf rust and red pepper anthracnose. It also showed 7-day and 4-day protective 
activities against the plant diseases. Three antifungal resorcinols were isolated from 
the methanol extract of Myristica malabarica fruit rinds and identified as 
malabaricones A (MA), B (MB), and C (MC). Inhibitory activity of the three 
resorcinols against mycelia growth of plant pathogenic fungi varied according to 
compound and target species. All three compounds effectively reduced the 
development of rice blast, wheat leaf rust and red pepper anthracnose. In addition, 
MC was highly active for reducing the development of tomato late blight. This is the 
first report on the antifungal activities of malabaricones against filamentous fungi. 
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Patro et.al 2008 Reported the 1,1-diphenyl-2-picrylhydrazyl (DPPH) assay of the 
ether, methanol, and aqueous extracts of the medicinal plant Myristica malabarica 
(rampatri) revealed the methanol extract to possess the best antioxidant activity. 
Column chromatography of the methanol extract led to the isolation of a new 2-
acylresorcinol and four known diarylnonanoids of which the diarylnonanoid, 
malabaricone C, showed the maximum DPPH scavenging activity. Malabaricone C 
could prevent both Fe(II)- and 2,2'-azobis(2-amidinopropane) dihydrochloride-
induced lipid peroxidation (LPO) of rat liver mitochondria more efficiently than 
curcumin. The anti-LPO activity of malabaricone C was attributed to its better free 
radical scavenging and Fe(II) chelation capacities. The superior activity of 
malabaricone C was rationalized by a systematic structure-activity correlation of the 
results obtained with the structurally related diarylnonanoids and curcumin. 
Malabaricone C also prevented the gamma-ray-induced damage of pBR322 plasmid 
DNA in a concentration-dependent manner. The radioprotective activity was found to 
correlate with its OH radical scavenging property, which matched well with that of d-
mannitol. 
Purushothaman et.al 2016 isolated Malabaricones A--D, novel diarylnonanoids from 
Myristica malabarica Lam (Myristicaceae).He was reported Four novel 
diarylnonanoids, malabaricones A–D, have been isolated from the fruit rind of 
Myristica malabarica Lam (Myristicaceae) and assigned the structures (1)–(4). 
Rupashree Sen et.al 2007 studied the antileishmanial activity of the fruit rind of 
myristica malabarica. that is used as a spice and is also credited with medicinal 
properties. The antipromastigote activity of different extracts/fractions of Myristica 
malabarica and its constituent diarylnonanoids were evaluated in Leishmania 
donovani promastigotes (MHOM/IN/83/AG83) using the MTS-PMS assay. 
Preliminary screening of the ether extract (R1) with its crude methanol fraction (R2) 
and two fractions (R3 and R4) revealed that R2 had potent leishmanicidal activity 
(IC50 31.0 µg/mL), whereas R3 and R4 showed poor activity. Fractionation of R2 
yielded four diarylnonanoids (malabaricones A–D, designated as Mal A, Mal B, Mal 
C and Mal D, respectively). The IC50values of Mal A–D were 16, 22, 27 and >50 
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µg/mL, respectively. Taken together, the data suggest that the methanol extract of 
Myristica malabarica, especially its constituent compounds, Mal A and Mal B, have 
promising anti leishmanial activity meriting further investigations regarding the 
underlying molecular mechanism(s) of action with a view towards future drug 
development. 
Ramabhati et.al 2007 Conducted  ecological studies on Myristica swamp forests in 
Uttara Kannada district of Karnataka state in India with reference to floristic 
composition, structure, diversity and edaphic factors were conducted. Transect 
method was employed by laying out sample plots in Kathalkane Reserve Forests of 
Western Ghats and enumeration of all trees >10 cm diameter at breast height was 
made. Sixty three species, including one unidentified species of trees and bamboos 
belonging to twenty six families with DBH >10 cm were recorded. The forest is of 
evergreen type dominanted by Myristica fatua var. magnifica, Gymnacranthera 
farquhariana, Hopea ponga and Dipterocarpus indicus. Myristicaceae dominated the 
swamps with maximum Importance Value Index of 102.63 represented mainly by G. 
farquhariana (57.83) and M. fatua var. magnifica (38.49). The forest floor is covered 
by knee roots. The physico-chemical properties of the soil of swamp were also 
determined. Endemism was fairly high, with 23 species endemic to the Western Ghats 
and ten species were rare and threatened. Soils were silty and sandy loam of acidic to 
neutral pH and moderate organic carbon levels. Soil nitrogen, phosphorous and 
potassium contents were in theranges 0.64-1.26%, also slightly lower than other forest 
ecosystems of the region.  
 Ribatti et.al 2008  Reported the Chick embryo chorioallantoic membrane is one of 
useful method of screening the angiogenesis and antiangiogenesis activity. The chick 
embryo chorioallantoic membrane (CAM) is an extraembryonic membrane mediating 
gas and nutrient exchanges until hatching. Because it has a dense capillary network, it 
has been commonly used in vivo to study both angiogenesis and antiangiogenesis in 
response to normal tissues and cells, to tumor bioptic specimens and cells, or to 
soluble factors. During the last 8 years, this assay has been used in over 550 published 
works.  The angiogenic response of CAM to multiple myeloma and neuroblastoma 
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cells and bioptic specimens and their responses to antiangiogenic molecules and the 
role played by fibroblast growth factor-2 in CAM vascularization have been analyzed 
in detailed manner and published .  
Sabulal Baby et.al 2007 identified and reported the chemical composition of the leaf 
oils of myristica malabarica (Myristicaceae) were isolated by hydrodistillation and 
analyzed by GC/FID and GC/MS. Seventy-six constituents (98.5%) with ȕ-
caryophyllene (27.3%), α-humulene (13.8%) and α-copaene (11.5%) as major 
components were identified from the leaf oil of Myristica malabarica. Sesquiterpene 
hydrocarbons constituted 77.3% in Myristica malabarica leaf oil. 
Swapnil Balasaheb Patil et.al 2011 studied and reported the Spices are extensively 
used to enhance the taste and flavor of foods and are known to possess several 
medicinal properties. Myristica fragrans, Parmelia perlata, Illicium verum, 
Trachyspermum copticum and Myristica malabarica, the commonly used spices in 
India were assessed for antidiabetic activity in streptozotocin induced diabetic rats. In 
the in vitro insulin secretion studies on isolated islets of Langerhans, M. fragrans, T. 
copticum and M. malabarica showed dose dependent insulin secretion. M. 
malabarica showed the highest flavonoid content (i.e., 38.35 mg quercetin 
equivalents/g). Regular use of these spices may prevent postprandial rise in glucose 
levels through inhibition of intestinal alpha-glucosidase and may maintain blood 
glucose level through insulin secretagogue action. 
Talukdar et.al 2000 Investigated the phytochemical constituents of an isoflavone 
from myristica malabarica and reported the isolation of the new 7,4′-dimethoxy-5-
hydroxyisoflavone together with two other isoflavones, biochanin A and prunetin, and 
a 1,3-diarylpropanol and a rare α-hydroxydihydrochalcone. 
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3. PLANT PROFILE 
 MYRISTICA MALABARICA   
 
DESCRIPTION 
Family   : Myristicaceae  
 Kingdom  : Plantae 
 Genus   : Myristica 
 Species  : Myristica malabarica                     
 Habit   : Tree 
 Habitat  : Evergreen Forests 
 Altitude  : 100 -800m 
 Higher classification : Nutmeg 
Vernacular Names   
Malayalam -kattujathi 
Hindi  -Van jayaphal 
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Kannada -Kanage,Dhodda jaye kaayi 
Telugu  -Rampatri 
Tamil  -Pathiri,Kattu jaathi kaai 
Sanskrit - Malati 
DISTRIBUTION 
 Endemic to Western Ghats in southern states of Karnataka and Kerala.  
 In Karnataka, occurs in evergreen forests of lower altitudes in Dakshina kannada, 
Uttara Kannda, Shimoga and Udupi districts. In Kerala, fairly common in the 
evergreen forests of lower Ghats. Not reported from Tamil Nadu. 
DESCRIPTION  
 It is a medium sized dioecious evergreen tree, growing 10-17m tall and about 
1.5m girth. Bark greenish-black, smooth, with projected lenticels, about 1 cm thick, 
partially fibrous, red inside, exuding deep red watery juice when cut fresh. Wood 
yellowish brown, tinged with grey, moderately hard. Branchlets hairless. Leaves 
alternate, linear-oblong or elliptic-oblong, 8-16x3-5cm, base rounded, apex acute, 
margin entire, hairless, glossy, leathery, distinctly stalked; lateral nerves 8-14 pairs, 
slender and faint. 
 About its flowers Male and female flowers seen in separate trees. Male 
flowers clustered at the end of branches of panicles, with slender stalks, 5-6mm long, 
creamy white, more or less hairless. Female flowers in small fascicles, ovoid, about 
6mm long, dull yellow. Capsusles solitary or in pairs, cylindrcially oblong, 5-9x3-
5cm, brown tomentose. Seeds single, completely covered by golden yellow or red-
cloured fleshy aril. 
TRADE DETAILS 
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  Local and regional. A possible adulterant to Myristica fragrans. The mace of 
Myristica malabarica commercially known as Rampattari is often adulterated with the 
true Jaatipatri (Myristica fragrans). Kernels are sometimes mixed with those of M. 
fragrans, the true source of Jaaiphal. 
SPECIAL FETURES 
 The bark exudes deep red watery juice when cut. Fruits are cylindrical, brown 
tomentose, splitting vertically by 2 valves, exposing seeds completely covered with 
brightly coloured dissected aril.  
MODE OF PROPAGATION 
 By seeds and stem cuttings 
MEDICINAL USES 
 Aril of the seeds is used to check cough, bronchitis, fever and burning 
sensation. Fat obtained from the seeds relieves pain in muscles, sprains and sores. 
 Myristica malabarica  Houtt) is an evergreen thick shady tree which produces 
high commercial value nuts and aril (mace).Being known for its wide coverage of use 
in Pharmaceutical as well as nonPharmaceutical, we thought of having an insight to 
its full potentiality. On literature review we came to know that the fruit-seed structure 
is not that simple; at a point we were jumbled to differentiate the seed part in its dry 
form. Since gathering farming practice directly from the field gives a live observation, 
we decided to collect the specimen directly from a  plantation and with the help of a 
botanist identify the parts. Nakshatra Extract Life Sciences (NELS) have its organic 
farm where  trees are being cultivated as a major crop as an intercropping between 
coconuts. Other spices including pepper and many other fruit yielding trees added 
value to the farm which follows good farming practice (GFP) under experienced 
technical hands. The details regarding cultivation, collection, processing and products 
of  were procured directly from their botanist, also from Pharmacopoeias, various 
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literatures and online data. The information available on the Pharmacognostical, 
Pharmacological, and Chemistry of  (Myristica malabarica ) has been extensively 
reviewed including details about cultivation parameters and usage. 
 Myristica malabarica  Houtt, commonly known as Jathikka and Javitri in 
India, belongs to the family Myristicaceae. The name ‘Myristica’ is derived from the 
Greek word ‘Myron’, a sweet liquid distilled from the plant. M.malabarica is one of 
the aromatic plants that are endowed with alluring properties of fragrance and 
flavours and produces odoriferous secondary metabolites in their fruits. No wonder, 
the  and mace have been popular for several hundreds of years. Geographical source 
Originated from the Banda Islands in the Moluccas of Eastern Indonesia, it is seldom 
found truly wild. It is now cultivated in tropical regions, especially Grenada in the 
West Indies, Sri Lanka and India Biophysical limits The plant grows at an altitude of 
700-4500m with a temperature 25-30ºC. It requires a rainfall of 2000-3500mm. can 
grow on any kind of soil provided there is sufficient water but without any risk of 
water logging. It prefers soils of volcanic origin and those with high contents of 
organic matter with pH 6.5-7.5. Pharmacognostical details of the plant It is a 
spreading aromatic evergreen tree usually growing to 5 to 13 metres high, 
occasionally 20 metres. The pointed dark green leaves are arranged alternately along 
the branches and are borne on leaf stems about 1 cm long. Upper leaf surfaces are 
shiny. Flowers are usually single sexed; occasionally male and female flowers are 
found on the same tree. Female flowers arise in groups of 1 to 3; males in groups of 1 
to 10. Flowers are pale yellow, waxy, fleshy and bell-shaped. The fruits are fleshy, 
drooping, yellow, smooth, 6 to 9 cm long with a longitudinal ridge. Fruit is yellow in 
colour having a shiny outer coat (exocarp) and a fleshy mesocarp below. Exocarp, 
mesocarp and endocarp together comprises the pericarp of the fruit. When ripe, the 
succulent yellow fruit (mesocarp) splits into 2 valves revealing a purplish-brown, 
shiny seed () surrounded by a red aril (mace). Seeds (s) are broadly ovoid (2 to 3 cm 
long), firm, fleshy, brownish-white and transversed by red-brown veins.  is the seed 
kernel inside the fruit and mace is the fleshy red,net like skin covering (aril) over the 
kernel. Oil seed is within the seed coat (endocarp) which gets detached after drying. 
Testa and tegmen are the layers of seed while perisperm have oil ducts within the 
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endosperm which also houses embryo. When fresh, the aril (mace) is bright scarlet 
becoming more horny, brittle and a yellowish-brown colour when dried (Purseglove, 
1968). The trees do not give flowers until around 9 years old, but once start flowering 
they continue to do so for further 75 years. The trees bear 2 to 3 crops a year. The 
seeds (s) need 3 to 6 weeks to dry before they are ready for use. Digital pictures 
representing various parts of  yield and its artistic illustration is shown in figure 1 and 
2 respectively. Figure 2 E and F shows partly removed calyx of male and female 
flower. 
 Cultivation, processing and harvesting Young  plants should be planted under 
50% shade, but can be reduced progressively and after 6-7 years they can grow 
without shade at all. Trees should be well spaced so that branches don’t touch each 
other and not to hamper flowering. Lower branches should be pruned to facilitate 
collection of dropped seeds. On our visit to organic farm of ‘Nakshtra extracts Life 
Sciences’ we were informed by their skilled resource person that as the tree grows the 
tap root degenerates and the fibrous roots become more active superficial feeders 
which provides the buoyancy for the entire tree. 1.5. Propagation The main problem is 
segregation of seedlings into male and female plants, resulting in the production of 
50% unproductive male plants. So it’s better to adopt budded or grafted plants. 
Grafted plants are planted into the main field during the beginning of rainy season. 
Pits of 0.75m×0.75m×0.75m size are dug at a space of 9m×9m and are filled with 
organic manures and soil 15 days prior to planting. A male graft has to be planted for 
every 20 female plants in the field. Plants should be shaded in order to be protected 
from sun. It can be best when grown as ntercrop in coconut gardens which are more 
than 15 years old. 1.6. Manures and fertilisers Information collected from organic 
farm of Nakshtra extracts Life Sciences recommends that care should be taken to 
avoid both water logging and drying of the soil since the tree is hydro sensitive. 
Ideally, 3-4 water sprinklers provide optimum watering during summer. Many 
farmers’ supply bone meal (for calcium), goat droppings/ dried cow dung to  base 
without disturbing roots which are superficial feeders. Levigation of mud on top of 
the manure helps its easy digestion. 
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 Harvesting The female trees start fruiting from 6 years old even though peak 
period is 20 years. The peak harvesting season is June–August. The fruits are ready 
for harvesting when the pericarp splits open. After harvesting outer fleshy part is 
removed and the mace is removed from the nut followed by sun drying. There are 
people who practice drying over native wood fire stove, especially during monsoon. 
The scarlet coloured mace becomes yellowish brown and brittle when drying is 
completed. The fleshy pericarp can be used for making jams, pickles and jellies. 1.8. 
Varieties Indian Institute of Spices Research has released ‘IISR vishwasree’ which 
yield about 1000 fruits at the 8 th year of planting. IISR has also released few elite 
lines such as A9- 20, 22, 25,69,150, A4-12,22,52, A11-23,70 as high yielders and 
distributed as grafts. 1.9. Pests and diseases The most serious pest is the scolytid 
beetle Phloeosinusribatus which bores through bark causing dieback and death. Other 
damaging borers are Xyleborusfornicatus and X. myristcae. The coffee bean weevil 
Ataecerus fasciculatus is a serious pest of stored  and mace. The only fungal disease 
of major importance is Stigmina myristicae, a dry rot that causes the fruits to open 
when still young. Consequently the arils and seeds remain underdeveloped and are 
worthless. Soft rot of fruits caused by Colletotric humgloeosporioides also causes 
young unripe fruits to open prematurely. Root rots caused by Fomesnoxius and 
Fomeslamaoensis may cause considerable damage. While most of the farmers depend 
on 1% bordeaux mixture (CUSO4: lime: water in the ratio of 1:1:100) for fungal rots, 
NELS practice 1% Pseudomonas solution as spray which is beneficial to preserve 
proper soil biosystem. It is mandatory to maintain the  field neat and tidy to avoid 
plant diseases and mosquitos which may be attracted by water filled split fruit coat. 
Many farmers supply neem cake to the tree base. 1.10. Chemical composition of 
Myristica malabarica  fruit The seed contains about 10% essential oil (Verghese 2001; 
Maya et al. 2004), which is mostly composed of terpene hydrocarbons (a-pinenes, 
camphene, p-cymene, sabinene, b-phellandrene, gterpinene, limonene, myrcene (60% 
to 90%), terpene derivatives (linalool, geraniol, terpineol-5% to 15%) and 
phenylpropanes (myristicin, elemicin, safrole-2% to 20%). The presence of myristicin 
and elemicin, in the seed of M. malabarica  is one of the reasons for its intoxicating 
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effects  has made extensive studies on the composition of  and mace. The seeds also 
contain 25-30% fixed oils (myristic, stearic, palmitic, oleic, linoleic and lauric acids). 
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4. AIM AND OBJECTIVE 
 Cancer is a one of the life threatened disease in this world and now a days 
which may appeared worldwide problem. As per the literature survey,  globally one in 
five men and one in six women will develop cancer before the age of 75 and one in 
eight men, and one in twelve women, will die from the disease. Nearly seven lakh 
Indians die of cancer every year, while over 10 lakh are newly diagnosed with some 
form of the disease.  Several modern day synthetic drugs are available in market do 
not full fill the requirements with side effects like allopecia, cytotoxicity, bone 
marrow depression etc. So the priority is drugs which minimize the side effects and 
also require a chemical entity for the treatment of cancer. Several literatures indicated 
traditional herbs possessing lesser side effects compared to synthetic drugs. The 
herbal formulations were developed from Ayurveda, traditional system of Indian 
medicine and its additional systems of medicine, has been found to have anticancer 
activity. Some of the research workers published has been published my study related 
species like Myristica Fragrance possess anti-cancer activity. Myristica Malabarica 
is a traditionally used herb but there is no scientific validation which old version of 
books and oliaichuvadi (Palmleaf petal writings) anti angiogenesis activity. Based on 
the above information’s I was selected the plant, perform the extraction and current 
work aims for identification of anticancer constituents from the fruits of Myristica 
Malabarica and evaluated by using some in vitro technique.  
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5. PLAN OF WORK  
 Collection and authentification of the genuine plant material from its natural 
source. 
  Extraction of the plant material using ethyl acetate in reflux apparatus name 
of the apparatus. 
 Extraction of the dried seeds of the myristica malabarica by using alcohol, 
chloroform, petroleum ether, ethyl acetate and water. 
  Preliminary screening of the ethyl acetate extract of the plant using specific                                       
chemical tests. 
 To perform thin layer chromatography to be find out the nature of volatile and 
solubility of compounds by using different solvent system. 
 Anti angiogenesis study using different extracts of myristica malabarica. 
 Selection of the fraction with higher activity. 
  In vitro cytotoxicity study (MTT ASSAY) by using cancer cell lines.   
  Identification of the chemical compounds present in the active fraction using 
LCMS analysis. 
  Prediction of biological activity of each constituent by using Bio-informatics 
software PASS. 
 Conforming the predicted anti cancer activity of active constituents from 
literature. 
  Conclusion of the work. 
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6. MATERIALS AND METHODS 
6.1 Collection of the plant 
Dried plant materials were collected from the Raw Drug Maker. Collected 
plant material was then shade dried and powdered. 
Requirements 
Instruments 
 Chemicals 
 Solvents 
 Drugs 
 Cells 
6.2 Extraction of Plant Material 
Extraction:1 
 About 1kg of the powdered sample was weighed and extracted with 
1000ml ml of Ethyl acetate (Merck, Germany) by reflux method. After the reflux, 
extract was collected dried under reduced pressure, which stored in desiccators. 
Complete moisture was removed from extract, which used for preliminary 
Phytochemical Screening, Thin Layer Chromatography, LCMS and invitro studies.( 
write any one method of extraction).. 
Extraction:2 
 About 2kg of the plant materials was extracted with 1000ml methanol 
(Merck, Germany) using Reflux method. The extract was then cooled, filtered and 
concentrated to dryness. It was then dissolved in 100 ml methanol. This extract was 
then subjected to Thin Layer Chromatography. 
 If the response to the test is high it can be noted as +++which indicates that the 
particular group is present as the major class. 
 If the response is average then note it as ++ indicates the presence in moderate 
quantity. 
 If the response is very small then note it as + indicating the presence of only in 
traces. 
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 If no response is then negative. 
 
6.3 PRELIMINARY PHYTOCHEMICAL SCREENING OF THE PLANT 
The Ethyl acetate leaf extract of was used for testing preliminary 
phytochemical screening in order to detect major chemical groups. 
Test for carbohydrates 
 Molisch’s test: Dissolved small quantity of 300mg alcoholic and dried leaf extract 
powder of Pimenta dioica separately in 4ml distilled water and filtered. The filtrate 
was  
 Fehling’s test: Dissolve a small portion of extract in water and treat with Fehling’s 
solution  
 Phenols test: The extract was spotted on a filter paper. A drop of phosphomolybdic 
acid reagent was added to the spot and was exposed to ammonia vapours. 
 Test for flavonoids  
Shinoda test: To 2 to 3ml of extract, a piece of magnesium ribbon and 1ml of 
concentrated HCl was added ..Lead acetate test: To 5ml of extract 1ml of lead acetate 
solution was added. 
Test for tannins 
 Braemer’s test: To a 2 to 3ml of extract, 10% alcoholic ferric chloride solution 
was added.  
Test for steroid/terpenoid 
 Liebermann-Burchardt test: To 1ml of extract, 1ml of chloroform, 2 to3ml of 
acetic anhydride and 1 to 2 drops of concentrated Sulphuric acid are added.  
Test for alkaloids 
 Draggendorf’s test: A drop of extract was spotted on a small piece of 
precoated TLC plate and the plate was sprayed with modified Draggendorf’s 
reagent  
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 Hager’s test: The extract was treated with few ml of Hager’s reagent.  
 Wagner’s test: The extract was treated with few ml of Wagner’s reagent. Tests 
for Glycosides 
 Legal’s test: Dissolve the extract [0.1g] in pyridine [2ml], added sodium 
nitroprusside solution [2ml] and made alkaline with Sodium hydroxide 
solution 
Test for Saponins 
 Foam test: 1ml of extract was dilute with 20ml of distilled water and shaken 
with a graduated cylinder for 15 minutes. 
 Test for Anthraquinones 
 Borntrager’s test: About 50 mg of powdered extract was heated with 10% 
ferric chloride solution and 1ml of concentrated HCl. The extract was cooled, 
filtered and the filtrate was shaken with diethyl ether. The ether extract was 
further extracted with strong ammonia.  
Test for Amino acids 
 Ninhydrin test: Dissolved a small quantity of the extract in few ml of water 
and added 1ml of ninhydrin reagent 
Test for fixed oils and fats 
Press small quantity of the petroleum ether extract between two filter paper.  
6.4 ANTI ANGIOGENISIS STUDY  
The  Myristica Malabarica different extracts are suspended by 0.5% carboxy methyl 
cellulose which was used for the invitro studies . For each series of strength required 5 
country eggs were taken per group. Each egg should be hold the vertical manner and 
oval portion at the upper side has cut by using a surgical blade a small portion of the 
upper part of the egg is cut open in a round manner, without loss of the outer 
membrane. Accurately diluted forms of extract were transferred by using small 
capillary tube insert into the egg and slowly administer by syringe and the open part is 
close with the membrane coated portion of the egg. The opened portion of the egg is 
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tightly close to prevent the air contamination into the egg, which was kept in a aseptic 
condition. Similarly the each concentration of the extracts were done in a same 
manner. .Totaly 25 eggs are use for the analysis. The solvent, drug and extract treated 
eggs were kept in a incubation period of 21 days for incubator. .After 21st day the egg 
is cut open and kept the content in a petridish and analyse the anti angiogenesis 
activity. 
6.5 INVITRO CELL LINE STUDY (CYTO TOXICITY STUDY) 
MTT ASSAY 
 MTT Assay is a type of calorimetric assay which involves the measurement of 
the enzyme in the cells which converts dye MTT to blue forzaman(refer). Main 
application of this method was to determine the viability and proliferation of the cells. 
It is mainly used to determine the cytotoxicity of the medicinal agents such as plant 
extract. The main disadvantage is it can be only applied to biological  cells . 
CELL LINES AND CULTURE MEDIUM 
 HCC 2935 and HCC4006 cell lines (human lung cancer) cell line culture were 
produced from National centre for cell lines(NCCS). pune, india. Stock cells of 
HCC2935 and HCC4006 cell lines were cultured in DMEM  supplemented with 10% 
inactivated fetal bovine serum(FBS), penicillin 
(100IU/ml),streptomycin(100mcg/ml),and amphotericin B(5mcg/ml),in humidified 
atmosphere of5%CO2 at 37C until confluent. The cells were dissociated with TPVG 
solution (0.2% trypsin,0.02%EDTA,0.05%Glucose in PBS).The stock culture were 
grown in 25cm2  culture flasks and all experiments were carried out 96 microtitre 
plates (Tarson India Pvt Ltd.,Kolkata.India). 
PROCEDURE 
Preparation of of test solutions 
For toxicity studies weighed test drug were  dissolved in distilled DMSO and 
volume was made up with DMEM supplemented with 2% inactivated foetal bovine 
serum to obtained a stoke solution of 1 mg/ml concentration and sterilised by 
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filtration. Serial two fold dilutions were prepared from this for carrying out cytotoxic 
studies. 
Assay procedure 
Step 1: Adjustment of cell count: 
 The monolayer of cell culture was trypsinized and the cell count was adjusted 
with DMEM medium containing 10% FBS to1.0*105 cells/ml. 
Step2: Addition of cell suspension: 
To each well of the 96 well microtitre plate, 0.1ml of the diluted cell 
suspension was added. 
Step3: Addition of Test Compound 
 After 24hrs, partial monolayer was formed, then supernatant was flicked 
off,and the monolayer washed once with medium. Then 100mcl of different test 
concentration of test compound were added on to the partial monolayer in microtitre 
plates. 
Step4: Incubation Period: 
 The plates were then incubated at 370 c in 5% co2 atmosphere, and 
microscopic examination was carried out and observation were noted every 24hrs of 
interval. 
 After 72hrs,the drug solution in the wells were discarded and 50mcl of MTT 
in PBS was added to each well. 
Step 6: Incubation Period: 
 The plates were shaken gently and incubated for 3hrs at 370 c in co2 
atmosphere. 
Step 7: Separation of Forzaman: 
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 The supernatant was removed and 100mcl of propanlol was added and the 
plates were gently shaken to solubilise the forzaman. The absorbance of the solution 
obtained was measured using a microplate reader at a wave length of 540nm. 
Calculation 
  The percentage growth inhibition was calculated by using the following 
formula and concentration of test compound needed to inhibit cell growth by 
50%(CTC50) Values is generated from the dose-response curve for each cell. 
Percentage growth inhibition= 100-OD of individual test group*100 
                                                                 OD Mean value 
6.6 METHODOLOGY FOR THE LC-MS ANALYSIS 
 LC-MS has become method of choice in many stages during drug 
development process. Recent advances includes electrospray, thermospray, and 
ionspray ionization techniques which offer unique advantages of high detection 
sensitivity and specificity, liquid secondary ion mass spectroscopy, later laser mass 
spectroscopy with 600 MHz offers accurate determination of molecular weight 
proteins, peptides. Isotopes pattern can be detected by this technique. For the most 
recent LC-MS on the market, an automatic procedure is included in the software 
package to tune and calibrate in the ESI mode. However, olderinstruments and/or very 
specific applications still require manual or semiauto-matic procedures to optimize the 
parameters that affect ion detection. In anLC-MS instrument, the mass spectrometer is 
tuned and calibrated in three steps:(1) ion source and transmission optimization, (2) 
MS calibration, and (3) fine tuning. As per the above specified standard procedure 
based to set specifications such as LC Column: Reverse Phase C-18, Pump: SPD 10 
AVP, Mobile Phase: Water: Methanol: THF (50:40:10), Ionisation Mode: Electronic 
Spray Ionization, Mode: Both Positive, Injection Volume: 10 Micro litre, Flow rate: 
1.5 ml/min, Column temperature: 250c, Column: PHENOMENEX RP 18, Column 
dimension: 25 cm x2.5 mm, LC Detection: 264 nm, M/Z Range: 50-1000  and Soft 
ware: Class V P Integrated and Library: Metwin 2.0 
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6.7 PASS (Prediction of activity spectra of substances) 
PRINCIPLE 
 PASS is the computer generated program which provides the simultaneous 
prediction of several hundreds of biological activity types for any drug-like 
compounds. In this bio informatics software prediction is based on the analysis of 
structure-activity relationships of (SAR) the training set including more than 30000 
known biologically active compounds. In this paper mainly investigate the influence 
on the accuracy of predicting the types of activity with PASS by (a) reduction of the 
number of structures in the training set and (b) reduction of the number of known 
activities in the training set. Here mainly demonstrate that predictions are robust 
despite the exclusion of up to 60% of information .The compounds from the MDDR 
database are used to create heterogeneous training and evaluation sets . 
 
PROCEDURE 
 To estimate the activity spectrum for a new compound (C) its MNA 
descriptors are generated. For each type of activity (j) the value of tjC is calculated. 
The probabilities of presence Paj and absence Pij of j-th activity type in the compound 
are calculated according to the next equations Aj(Pa) ) tjC; Ij(Pi) ) tjC In other words, 
Pa and Pi are the probabilities of belonging to the classes of active and inactive 
compounds, respectively. The result of prediction for a new compound is the activity 
spectrum, which is the ranked list of activity types with estimated Pa and Pi values. 
The ranking is executed on descending order of Pa-Pi; thus, more probable activity 
types are at the top of predicted spectrum. Compound is considered as active if Pa-Pi 
exceeds the cut off value. By default  here use cut off of Pa - Pi 0, but any user may 
accept his own cut off value. 
 
 
 
  
Department of Pharmacology    43     J.K.K.Nattraja College of Pharmacy 
 
7. RESULT AND DISCUSSION 
 
Class of  compounds Tests performed Results  
Carbohydrates Molisch’s test 
Fehling’s test 
+ 
Phenols Phosphomolybdic acid test +++ 
Flavonoids Shinoda test 
Lead acetate test 
++ 
Tannins Braemer’s test _ 
Alkaloids Wagner’s 
Mayer’s 
Draggendrof’s test 
+ 
Glycosides Legal’s test 
Brontranger’s test 
+ 
Saponins Foam test _ 
Sterols Salkowski’s test ++ 
Aminoacids Ninhydrin test _ 
Terpenoids Libermann Burchardt test + 
 
 The phytochemical studies results revealded that the  Molisch’s test. 
Formation of reddish brown ring indicated the presence of carbohydrates.  Blue 
coloration of the spot indicated the presence of phenols. A pink or red coloration of 
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the solution indicated the presence of flavonoids in the drug. Flocculent white 
precipitate indicated the presence of flavonoids. Dark blue or greenish grey coloration 
of the solution indicated the preseence of tannins in the drug. Dark green coloration of 
the solution indicated the presence of steroids and dark pink or red coloration of the 
solution indicated the presence of terpenoids. Orange coloration of the spot indicated 
the presence of alkaloids. Yellow precipitation indicated the presence of alkaloids. 
The reddish brown precipitation indicated the presence of alkaloids. Pink to red color 
solution indicates the presence of glycosides. A1cm layer of foam formation indicates 
the presence of Saponins. Pink or red coloration of aqueous layer indicated the 
presence of Anthraquinones. Blue color indicated the presence of amino acids. Oil 
stains on the paper indicated the presence of fixed oils. If the response to the test is 
high it can be noted as +++which indicates that the particular group is present as the 
major class. If the response is average then note it as ++ indicates the presence in 
moderate quantity. If the response is very small then note it as + indicating the 
presence of only in traces. If no response is then negative. 
NB:--- indicate not present 
+  In traces 
++   present in moderate amount 
+++ more amount is present 
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IN VITRO CELL LINE STUDY (MTT ASSAY) 
Cytotoxicity Effect Of myristica malabarica on colon cancer cell lines 
 
SI 
NO 
 
Cell Lines 
 
Name Of Drug 
 
Conc(mcg/
ml) 
 
% Inhibition 
Average 
CTC50(mcg/ml) 
 
 
1. 
 
 
HCC2935 
 
 
MYRISTICA 
MALABARICA 
6.25 
12.5 
25 
50 
100 
18.72+0.59 
35.6+ 2.8 
42.6+ 1.82 
57.36+ 5.04 
68.3+ 4.16 
 
 
44.51 
 
 
 
2. 
 
 
 
HCC4006 
 
 
 
MYRISTICA 
MALABARICA 
6.25 
12.5 
25 
50 
100 
15.45+ 1.55 
36.2+ .35 
45.2+ 0.68 
65.1+ 1.1 
75.2 + 1.55 
 
 
47.43 
  
The mean + standard error values were expressed which evaluated by one way 
ANOVA followed by Dunnet ‘t’ test 
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Cytotoxicity effect of myristica malabarica extract on HCC2935 Cell lines                
 
Cytotoxicity effect of myristica malabarica extract on HCC4006 Cell lines 
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TLC RESULTS OF MYRISTICA MALABARICA 
 
RF Value range 0-1-High polar substances 
Low RF Value- Higher polar substances may present 
Higher RF Value- Low polar substances may present 
Solubility of the compounds is directly proportional to polarity of the compounds.  
 
 
 
 
Si 
No 
Solvents Concentration RF Value 
1. Toluene+ Ethyl Acetate 7:3 0.53 
2. Ethyl Acetate+ Toluene +Glacial 
Acetic Acid 
5:5:1 0.66 
3. Petroleum Ether+ Chloroform 7:3 0.62 
4. Ethyl Acetate+ Methanol 1:1 0.46 
5. Hexane+ Dichloro Methane 1:1 0.47 
6. Ethyl Acetate+ Methanol 3:1 0.45 
7. Dichloro Methane+ Hexane 3:1 0.56 
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Myristica malabarica petroleum ether extract 
 
 
 
MMPE: Myristica malabarica Petroleum Ether Extract. 
10, 20, 30: mcg concentration 
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Myristica malabarica Ethyl acetate extract 
 
 
 
MMEA: Myristica malabarica Ethyl Acetate Extract 
10, 20, 30: mcg concentrations 
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Myristica malabarica Water extract 
        
 
 
MMW: Myristica malabarica Water Extract 
10, 20, 30: mcg concentrations 
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Myristica malabarica Alcohol extract 
 
 
 
MMAL: Myristica malabarica Alcohol Extract 
10, 20, 30: mcg concentration 
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Myristica malabarica Chloroform extract 
 
 
 
MMC: Myristica malabarica Chloroform Extract 
10, 20, 30: mcg concentration 
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8. DISCUSSION AND CONCLUSSION 
Angiogenesis is a hallmark of tumor development and metastasis and is now a 
validated target for cancer treatment. However, the survival benefits of anti-
angiogenic drugs have, thus far, been rather modest, stimulating interest in developing 
more effective ways to combine anti-angiogenic drugs with established 
chemotherapies. New targets for anti-angiogenesis continue to be discovered, 
increasing the opportunities to interdict tumor angiogenesis and circumvent resistance 
mechanisms that may emerge with chronic use of these drugs. 
The control of tumor angiogenesis is an integral part of the host defense 
response to tumor growth. Loss of endogenous angiogenesis inhibitors, such as 
endostatin and thromobospondin-1, leads to increased tumor angiogenesis and 
accelerates tumor growth. The inhibition of tumor growth by anti-angiogenic drugs 
has been achieved both in preclinical studies and in clinical trials, where promising 
anti-tumor responses have been reported for a variety of anti-angiogenic agents 
The survival benefits of anti-angiogenic drugs have, thus far, been rather 
modest, leading to increased interest in developing more effective ways to combine 
anti-angiogenic drugs with traditional, cytotoxic chemotherapies. In this review, we 
discuss recent progress and some emerging challenges in the development of anti-
angiogenic drugs for cancer treatment. 
Tumors need to develop their own blood vessels in order to survive, 
proliferate and invade other tissues, making antiangiogenesis an interesting target for 
antitumor therapy. Treatments can be direct, targeting membrane receptors, indirect, 
targeting angiogenic factors or both. 
Using chick CAM model ,the new pharmacological effect of Myristica 
malabarica extract have been confirmed by the proven inhibition of angiogenesis. It 
showed that significant antiangiogenic activity of all  hours of treatment studied and 
extract studies. 
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The antiangiogenic property of Myristica malabarica may be attributed to the 
phytochemical present in the plant .It could be function of either the individual or the 
additive effect of phytoconstituents may be phenol, terpinoids, and flavanoids have 
shown to inhibit carcinogenisis and tumerogenisis. 
From qualitative phytochemical analysis the presence of alkaloids ,flavanoids 
and terpinoids may be atributed to the potential antiangiogenic property . The strong 
antiangiogenic properties of this plant support the ethnomedical claim of the 
Myristica malabarica. 
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